Lim, HoTae
Choi, In Young
Hyun, Sang-Hwan
Kim, Hyesoo
Lee, Gabsang
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R01NS093213)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR070751)
Maryland Stem Cell Research Fund (2017-MSCRFD-3941)
Muscular Dystrophy Association (381465)
Article History
Received: 13 October 2020
Revised: 31 December 2020
Accepted: 28 January 2021
First Online: 15 February 2021
Compliance with ethical standards
:
: GL is a founder of the Vita Therapeutics. IYC, HTL and GL are shareholders of the Vita Therapeutics. SHH and HK declare no potential conflict of interest.